Sox9 expression is upregulated in both mouse and human BCC tumors [17] and was later shown to be a general marker of human BCC and additional hair follicle-derived tumors [37], consistent with its activation downstream of Shh signaling. The gene discussed is SOX9; the disease is skin basal cell carcinoma.